Literature DB >> 16884718

Pellino proteins are more than scaffold proteins in TLR/IL-1R signalling: a role as novel RING E3-ubiquitin-ligases.

Reinout Schauvliege1, Sophie Janssens, Rudi Beyaert.   

Abstract

Members of the Toll-like receptor (TLR) and IL-1 receptor (IL-1R) family initiate signalling pathways that shape innate immunity. Pellino proteins have recently been implicated as evolutionary conserved scaffold proteins in TLR/IL-1R signalling leading to nuclear factor-kappaB and mitogen activated protein kinase-dependent gene expression. We found that Pellino proteins contain a new RING-like motif. Because RING motifs are a feature of a subclass of E3-ubiquitin-ligases that target specific proteins for ubiquitination, we suggest that Pellino proteins are involved in TLR/IL-1R signalling not only as scaffold proteins but also as RING E3-ubiquitin-ligases. In support of this hypothesis we show that Pellino proteins induce IRAK-1 polyubiquitination in a RING-dependent manner. We further propose a model in which Pellino-mediated IRAK-1 polyubiquitination regulates TLR/IL-1R signalling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884718     DOI: 10.1016/j.febslet.2006.07.046

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  47 in total

1.  Pellino 2 is critical for Toll-like receptor/interleukin-1 receptor (TLR/IL-1R)-mediated post-transcriptional control.

Authors:  Tae Whan Kim; Minjia Yu; Hao Zhou; Wei Cui; Jianan Wang; Paul DiCorleto; Paul Fox; Hui Xiao; Xiaoxia Li
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 2.  Peli: a family of signal-responsive E3 ubiquitin ligases mediating TLR signaling and T-cell tolerance.

Authors:  Wei Jin; Mikyoung Chang; Shao-Cong Sun
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

Review 3.  Proteasome protease mediated regulation of cytokine induction and inflammation.

Authors:  Nilofer Qureshi; David C Morrison; Julia Reis
Journal:  Biochim Biophys Acta       Date:  2012-06-19

4.  MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells.

Authors:  Maurizio Ceppi; Patricia M Pereira; Isabelle Dunand-Sauthier; Emmanuèle Barras; Walter Reith; Manuel A Santos; Philippe Pierre
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-04       Impact factor: 11.205

Review 5.  Role of non-degradative ubiquitination in interleukin-1 and toll-like receptor signaling.

Authors:  Sinéad E Keating; Andrew G Bowie
Journal:  J Biol Chem       Date:  2008-08-06       Impact factor: 5.157

6.  Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis.

Authors:  Shuo Yang; Bingwei Wang; Fiachra Humphries; Ruaidhri Jackson; Marc E Healy; Ronan Bergin; Gabriella Aviello; Barry Hall; Deirdre McNamara; Trevor Darby; Aoife Quinlan; Fergus Shanahan; Silvia Melgar; Padraic G Fallon; Paul N Moynagh
Journal:  Nat Immunol       Date:  2013-07-28       Impact factor: 25.606

7.  Autophagy-dependent PELI3 degradation inhibits proinflammatory IL1B expression.

Authors:  Annika Klara Giegerich; Laura Kuchler; Lisa Katharina Sha; Tilo Knape; Heinrich Heide; Ilka Wittig; Christian Behrends; Bernhard Brüne; Andreas von Knethen
Journal:  Autophagy       Date:  2014-10-30       Impact factor: 16.016

8.  Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.

Authors:  Dietrich B Conze; Chuan-Jin Wu; James A Thomas; Allison Landstrom; Jonathan D Ashwell
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

9.  Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production.

Authors:  Mikyoung Chang; Wei Jin; Shao-Cong Sun
Journal:  Nat Immunol       Date:  2009-09-06       Impact factor: 25.606

10.  Pellino3 targets the IRF7 pathway and facilitates autoregulation of TLR3- and viral-induced expression of type I interferons.

Authors:  Jakub Siednienko; Ruaidhri Jackson; Mark Mellett; Nezira Delagic; Shuo Yang; Bingwei Wang; Lisa S Tang; John J Callanan; Bernard P Mahon; Paul N Moynagh
Journal:  Nat Immunol       Date:  2012-10-07       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.